Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21

6d ago, source:

The board of Royalty Pharma plc ( NASDAQ:RPRX ) has announced that it will pay a dividend of $0.21 per share on ...

Royalty Pharma PLC Class A RPRX

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Royalty Pharma declares $0.21 dividend

9d ago, source:

Payable June 14; for shareholders of record May 17; ex-div May 16.

Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

27d ago, source: Yahoo Finance

Royalty Pharma's (NASDAQ:RPRX) stock up by 8.1% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to ...

Royalty Pharma Stock (NASDAQ:RPRX), Analyst Ratings, Price Targets, Predictions

14d ago, source: Benzinga.com

$27.89 100.79% Goldman Sachs ...

Royalty Pharma Declares Second Quarter 2024 Dividend

9d ago, source: The Bakersfield Californian

NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ...

Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

27d ago, source: Yahoo Finance

Royalty Pharma's (NASDAQ:RPRX) stock up by 8.1% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to ...

RPRX Royalty Pharma plc

2mon ago, source: Seeking Alpha

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification ...

Royalty Pharma PLC Class A

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Royalty Pharma PLC

4d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...